Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- R-CHOPIndependent statistical analysis of Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- R-DISSOLVEIndependent statistical analysis of An Exploratory stuDy of effectIveneSs and Safety of rivarOxaban in Patients With Left VEntricular Thrombus (R-DISSOLVE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- R2Independent statistical analysis of Rasagiline Rescue in Alzheimer's Disease Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02359552).
- R21Independent statistical analysis of Early Menopause Hormone Treatment and Cognition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046643).
- R21 India Pal-Care Evaluation: Complete Statistical AnalysisIndependent statistical analysis of R21 India Pal-Care Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04972630).
- R2D2Independent statistical analysis of Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RA-BRANCHIndependent statistical analysis of A Study of Baricitinib in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04086745).
- RA-COMPAREIndependent statistical analysis of An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate: primary endpoint results, effect estimate with confidence interval,…
- RA-MOBILITYComplete statistical analysis of RA-MOBILITY, evaluating sarilumab on top of methotrexate in rheumatoid arthritis, including ACR20 response, HAQ-DI, structural damage, multiplicity, and registry-reported statistical results.
- RAAS and Arterial Stiffness in SCI: Complete Statistical AnalysisIndependent statistical analysis of RAAS and Arterial Stiffness in SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510974).
- RAAS-PARCIndependent statistical analysis of The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01691781).
- rAAV2-ND4Independent statistical analysis of Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD): Complete Statistical AnalysisIndependent statistical analysis of Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD): primary endpoint results, effect estimate with…
- RACE-PDIndependent statistical analysis of Remote Access to Care, Everywhere, for Parkinson Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02144220).
- Racial Discrimination and Stress Response: Complete Statistical AnalysisIndependent statistical analysis of Racial Discrimination and Stress Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05820659).
- Racial/Ethnic Differences in Microneedle Response: Complete Statistical AnalysisIndependent statistical analysis of Racial/Ethnic Differences in Microneedle Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03332628).
- RACINGIndependent statistical analysis of Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RADIndependent statistical analysis of Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients: primary endpoint results, effect estimate with confidence…
- RAD 2003Independent statistical analysis of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04743934).
- RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment: Complete Statistical AnalysisIndependent statistical analysis of RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RAD001 and Erlotinib in Patients With Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of RAD001 and Erlotinib in Patients With Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00843531).
- RAD001 Plus Bevacizumab in Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of RAD001 Plus Bevacizumab in Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00591734).
- RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RAD0201Independent statistical analysis of Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00581971).
- RAD1801Independent statistical analysis of RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RADARIndependent statistical analysis of Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00538759).
- RADAR-AIndependent statistical analysis of Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Radial Reload Laparoscopic LAR Case Series: Complete Statistical AnalysisIndependent statistical analysis of Radial Reload Laparoscopic LAR Case Series: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01706822).
- RADIANCYIndependent statistical analysis of Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access: primary endpoint results, effect estimate…
- RADIANTA detailed statistical analysis and educational interpretation of the RADIANT phase 3 trial of erlotinib versus placebo after surgery in EGFR-positive non-small cell lung cancer, focusing on disease-free survival and time-to-event methodology.
- RADIANTIndependent statistical analysis of Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RADIANT-TBIndependent statistical analysis of Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03851588).
- Radiation Dose Escalation in Esophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Dose Escalation in Esophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03082586).
- Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS): Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases: primary…
- Radiation Therapy in Treating Young Patients With Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy in Treating Young Patients With Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00238264).
- Radiation Therapy to Treat Musculoskeletal Tumors: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy to Treat Musculoskeletal Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00186992).
- Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…